Literature DB >> 7749534

Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach.

S Ohno1, S Tomisaki, H Oiwa, Y Sakaguchi, Y Ichiyoshi, Y Maehara, K Sugimachi.   

Abstract

BACKGROUND: Carcinoma arising in the cardioesophageal junction is a distinct clinical entity compared with tumors located in other regions of the stomach. This study was done to analyze the biologic characteristics of carcinoma of the gastric cardia compared with other gastric carcinomas. STUDY
DESIGN: Clinicopathologic features and postoperative prognosis of 68 cases of carcinoma of the cardia were evaluated, in comparison with findings of tumors in other regions of the stomach.
RESULTS: From 1975 to 1992, 68 (6.5 percent) of 1,042 patients with carcinoma of the stomach had adenocarcinoma of the cardia. Carcinoma of the cardia was characterized by a more advanced stage compared with carcinoma of other regions of the stomach. The incidence of early stage carcinoma (limited to the submucosal layer) was 11.8 percent in the cardia, 15.8 percent in the upper one-third, and 42.2 percent in the remaining middle and lower thirds of the stomach. When compared to carcinoma in other regions of the stomach, tumors of the cardia had a significantly poorer prognosis and there was a higher incidence of lymph node and hepatic metastasis. The five-year survival rates in patients with adenocarcinoma in the cardia, the upper one-third, and the remaining middle and lower thirds of the stomach were 35.3, 43.7, and 61.9 percent, respectively. Especially for patients with stage II and stage III disease, the prognosis was significantly worse with adenocarcinoma of the cardia than with carcinomas of the other regions of the stomach.
CONCLUSIONS: Early detection is crucial to improve the survival of patients with carcinoma of the gastric cardia. Extended dissection of lymph nodes and aggressive postoperative chemotherapy in an attempt to prevent hepatic metastasis are highly recommended.

Entities:  

Mesh:

Year:  1995        PMID: 7749534

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  29 in total

1.  Gastric Cancer.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  1999-06

2.  Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus White non-Hispanic.

Authors:  Babak Rajabi; Javier C Corral; Nawar Hakim; Zuber D Mulla
Journal:  Gastric Cancer       Date:  2012-01-18       Impact factor: 7.370

3.  Risk factors associated with early recurrence of adenocarcinoma of gastroesophageal junction after curative resection.

Authors:  Guodong Wang; Aiwen Wu; Xiaojing Cheng; Jiafu Ji
Journal:  Chin J Cancer Res       Date:  2013-06       Impact factor: 5.087

4.  Expression of ATP7B in human gastric cardiac carcinomas in comparison with distal gastric carcinomas.

Authors:  Da-Long Wu; Hui-Xing Yi; Feng-Ying Sui; Xiao-Hong Jiang; Xiao-Ming Jiang; Ying-Ying Zhao
Journal:  World J Gastroenterol       Date:  2006-12-21       Impact factor: 5.742

5.  Lymph node metastasis from cancer of the esophagogastric junction, and determination of the appropriate nodal dissection.

Authors:  Yoshihiro Kakeji; Manabu Yamamoto; Shuhei Ito; Masahiko Sugiyama; Akinori Egashira; Hiroshi Saeki; Masaru Morita; Yoshihisa Sakaguchi; Yasushi Toh; Yoshihiko Maehara
Journal:  Surg Today       Date:  2012-01-14       Impact factor: 2.549

6.  Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study.

Authors:  Daniele Marrelli; Alfonso De Stefano; Giovanni de Manzoni; Paolo Morgagni; Alberto Di Leo; Franco Roviello
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

7.  Incidence and survival for gastric and esophageal cancer diagnosed in British Columbia, 1990 to 1999.

Authors:  M Bashash; A Shah; G Hislop; A Brooks-Wilson; N Le; C Bajdik
Journal:  Can J Gastroenterol       Date:  2008-02       Impact factor: 3.522

8.  Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders.

Authors:  Stacey A Dacosta Byfield; Craig C Earle; John Z Ayanian; Ellen P McCarthy
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

9.  Clinicopathologic comparison of Siewert type II and III adenocarcinomas of the gastroesophageal junction.

Authors:  Norihiro Yuasa; Hideo Miyake; Tatsuharu Yamada; Tomoki Ebata; Yuji Nimura; Tatsuo Hattori
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

10.  Prognostic value of Goseki histological classification in adenocarcinoma of the cardia.

Authors:  M G Fontana; M La Pinta; D Moneghini; V Villanacci; F Donato; G Rindi; S Paparini; C Baronchelli; G Bertoli; P Alquati
Journal:  Br J Cancer       Date:  2003-02-10       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.